# Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial

Study · id `cardio:ct-nct03666806` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03666806](<https://clinicaltrials.gov/study/NCT03666806>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03666806

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT03666806. Randomized; quadruple masking; primary purpose prevention. Start 2018-08-22 (actual); primary completion 2019-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2/3
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT03666806, source copy `cardio:ctgov-nct03666806-2018-09-12`, retrieved 2026-10-26)
- Started: 2018-08-22 (actual) (ClinicalTrials.gov record NCT03666806, source copy `cardio:ctgov-nct03666806-2018-09-12`, retrieved 2026-10-26)
- Primary completion: 2019-09 (anticipated) (ClinicalTrials.gov record NCT03666806, source copy `cardio:ctgov-nct03666806-2018-09-12`, retrieved 2026-10-26)
- Completion: 2019-12 (anticipated) (ClinicalTrials.gov record NCT03666806, source copy `cardio:ctgov-nct03666806-2018-09-12`, retrieved 2026-10-26)
- Countries: Uganda (ClinicalTrials.gov record NCT03666806, source copy `cardio:ctgov-nct03666806-2018-09-12`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03666806-2018-09-12`, retrieved 2026-10-26)

## The registry's words

- Brief title: Preventing Stroke Triggers in Children With Sickle Cell Anaemia in Mulago Hospital, Kampala (PREST ): a Randomized Control Trial
- Acronym: PREST
- Condition: Preventing Stroke in Sickle Cell Anaemia
- Intervention (Biological): Influenza vaccine
- Lead sponsor: Makerere University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 6881a213a11f568a1ef92d20523a135db1c3615b10c0b260e85c921bc3aa6ec9
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
